Endocrinology, Vol 127, 2705-2708, Copyright © 1990 by Endocrine Society

ARTICLES

Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies

WB Wehrenberg, PJ Bergman, L Stagg, J Ndon and A Giustina
Department of Health Sciences, University of Wisconsin-Milwaukee 53201.

Clinically, glucocorticoids are important immunosuppressive hormones. Yet, these steroids are also potent inhibitors of growth. We hypothesized that glucocorticoids may partially inhibit growth by increased somatostatin (SRIF) secretion. We tested this hypothesis using passive immunization techniques. Male rats (approximately 50 g) were treated daily (ip) for 33 days with saline (SAL) or dexamethasone (DEX, 40 micrograms/kg) and every fourth day with normal sheep serum (NSS) or SRIF antiserum (SRIF-ab, 0.25 ml). Body wts were recorded daily. Groups (n = 6) were: 1) SAL + NSS, 2) SAL + SRIF-ab, 3) DEX + NSS, and 4) DEX + SRIF-ab. Regression analysis of the growth curves clearly demonstrated differences in body wt gain for the four treatment groups (P less than 0.01). Final body wt of SAL + NSS treated rats was 285 +/- 5 g and 285 +/- 12 g in SAL + SRIF-ab treated rats. DEX + NSS treated rats weighed significantly less (227 +/- 4 g, P less than 0.01) than SAL-treated rats. This glucocorticoid-induced decrease in body wt was partially reversed by the concomitant treatment of rats with SRIF- ab (241 +/- 6 g, P less than 0.05). This observation leads to the conclusion that the inhibitory effect of glucocorticoids on growth may be mediated, in part, by increased SRIF secretion.

This article has been cited by other articles:

				F. Pecori Giraldi, M. Andrioli, L. De Marinis, A. Bianchi, A. Giampietro, M. De Martin, E. Sacco, M. Scacchi, A. Pontecorvi, and F. Cavagnini Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease Eur. J. Endocrinol., February 1, 2007; 156(2): 233 - 239. [Abstract] [Full Text] [PDF]

				G. Tulipano, D. Soldi, M. Bagnasco, M. D. Culler, J. E. Taylor, D. Cocchi, and A. Giustina Characterization of New Selective Somatostatin Receptor Subtype-2 (sst2) Antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH Release in Anesthetized Male Rats after Short-Term High-Dose Dexamethasone Treatment Endocrinology, April 1, 2002; 143(4): 1218 - 1224. [Abstract] [Full Text] [PDF]

				J. A. Gusenoff, S. M. Harman, J. D. Veldhuis, J. J. Jayme, C. St. Clair, T. Munzer, C. Christmas, K. G. O'Connor, T. E. Stevens, M. F. Bellantoni, et al. Cortisol and GH secretory dynamics, and their interrelationships, in healthy aged women and men Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E616 - E625. [Abstract] [Full Text] [PDF]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]